Boston Cambridge Biotech Trending News

Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts

Pictured: Biogen’s signage at its headquarters in Massachusetts/iStock, JHVEPhoto Biogen and Ionis Pharmaceuticals on Thursday revealed early results from the Phase I/II ALSpire study, demonstrating that their investigational antisense oligonucleotide BIIB105 failed to significantly lower […]

Boston Cambridge Biotech Trending News

Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain

After promising results from first-in-man studies with its novel Neural Ice technology, the Massachusetts-based company will use the capital to initiate pivotal clinical studies in both chronic and acute pain indications CAMBRIDGE, Mass., May 14, […]

Boston Cambridge Biotech Trending News

Indico Data releases industry-first large language model benchmark for document understanding tasks

New quarterly benchmarking calculates accuracy and costs of major LLM providers using verified industry evaluation methods BOSTON, May 13, 2024 /PRNewswire/ — Indico Data, the industry’s leading solution for the automating of critical intake workflows […]

No Picture
Boston Cambridge Biotech Trending News

Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure

BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL‑HF, the first Phase 2 proof-of-concept clinical […]